Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) — Capital Reinvestment Ratio
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) has a Capital Reinvestment Ratio of 0.03x as of June 2023, meaning it reinvests 0% of its operating cash flow ($118.87 Million) in capital expenditures ($4.04 Million). Check 900904 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B Capital Reinvestment Ratio (2015–2024)
This chart tracks Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Shanghai Shenqi Pharmaceutical Investmen.
Annual Capital Reinvestment Ratio for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (2015–2024)
Year-by-year Capital Reinvestment Ratio for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B from 2015 to 2024. See free cash flow generation of Shanghai Shenqi Pharmaceutical Investmen to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.18x | $207.79 Million | $36.39 Million | ▲ +54.0% |
| 2023 | 0.11x | $215.59 Million | $24.51 Million | ▲ +36.2% |
| 2022 | 0.08x | $319.23 Million | $26.64 Million | ▼ -82.1% |
| 2021 | 0.47x | $184.26 Million | $85.96 Million | ▼ -52.0% |
| 2020 | 0.97x | $99.10 Million | $96.31 Million | ▲ +62.0% |
| 2019 | 0.60x | $128.28 Million | $76.96 Million | ▼ -19.2% |
| 2018 | 0.74x | $148.53 Million | $110.25 Million | ▼ -54.3% |
| 2017 | 1.62x | $66.99 Million | $108.84 Million | ▼ -97.8% |
| 2016 | 75.16x | $570.41K | $42.87 Million | ▲ +3320.6% |
| 2015 | 2.20x | $30.12 Million | $66.18 Million | — |